$ Value
$50K
Shares
1,694
Price
$30
Filed
Sep 9
Insider
Name
Basho Chandan
Title
COO and CFO
CIK
0001929126
Roles
Transaction Details
Transaction Date
2025-09-05
Code
F
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
176,946
Footnotes
Represents the surrender of shares to offset against tax withholding obligations associated with certain restricted stock units that vested on September 5, 2025. | Includes the following shares of unvested restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 7,214 shares, which will vest on April 14, 2026; and (ii) 30,404 shares, which will vest in two equal annual installments on May 16, 2026 and 2027. Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 23,404 restricted stock units, which will vest in six equal semi-annual installments beginning on October 2, 2025; and (ii) 23,364 restricted stock units, which will vest in seven equal semi-annual installments beginning on March 5, 2026.
Filing Info
Basho Chandan's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-14 | ASTH | F | $113K |
| 2026-04-02 | ASTH | F | $52K |
| 2026-03-05 | ASTH | F | $31K |
| 2025-10-02 | ASTH | F | $55K |
| 2025-09-05 | ASTH | F | $50K |
| 2025-05-16 | ASTH | F | $273K |
Other Insiders at ASTH (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| Lam Thomas S. | — | — | 2026-04-06 |
|
Sim Kenneth T.
Executive Chairman
|
— | — | 2026-04-06 |
|
Sim Brandon
CEO and President
|
— | — | 2026-04-06 |
|
Kumar Dinesh M.
Chief Medical Officer
|
— | — | 2026-04-01 |
|
Sobotka Glenn
Chief Accounting Officer
|
— | — | 2026-03-26 |
|
Basho Chandan
COO and CFO
|
— | — | 2026-04-14 |